期刊文献+

脓毒症患者抗菌药物药物代谢动力学和药物效应动力学研究进展 被引量:3

Research progress on pharmacokinetics and pharmacodynamics of antibiotics in sepsis
下载PDF
导出
摘要 脓毒症是机体对感染反应失调而引起的器官功能障碍,病死率很高,合理使用抗菌药物是降低脓毒症患者病死率的关键。但是临床抗感染治疗经常失败,原因之一是脓毒症患者对抗菌药物的药物代谢动力学(PK)和药物效应动力学(PD)发生了变化。因此,掌握PK和PD知识有助于正确应用抗菌药物,降低脓毒症患者的病死率。现拟对脓毒症患者PK变化以及通过PK和PD优化抗菌药物给药方案的相关研究进展进行综述。 Sepsis is a sequence of sequential organ dysfunction caused by imbalance of organism response to infection,and the mortality is very high.Rational use of antibiotics is the key to reduce the mortality of patients with sepsis.However,using antibiotics for treatment of sepsis clinically often obtains failure result.One of the causes is the occurrence of pharmacokinetic(PK)and pharmacodynamic(PD)changes of antibiotics in the septic patient,inducing the failure.Therefore,mastering PK/PD knowledge is conducive to the correct application of antibiotics and the reduction of mortality in septic patients.Here,the authors intend to review the progress of researches related to changes of PK in septic patients and via PK and PD to optimize antibiotic dosing regimens in sepsis.
作者 毛文超 李莉 严静 Mao Wenchao;Li Li;Yan Jing(The Second Clinical Medical College,Zhejiang Chinese Medicine University,Hangzhou 310053,Zhejiang,China;Department of Critical Care Medicien,Zhejiang Hospital,Hangzhou 310013,Zhejiang,China)
出处 《中国中西医结合急救杂志》 CAS CSCD 北大核心 2021年第5期634-637,共4页 Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
基金 国家自然科学基金(81772051)。
关键词 脓毒症 抗菌药物 药物代谢动力学 药物效应动力学 Sepsis Antibiotic Pharmacokinetics Pharmacodynamics
  • 相关文献

参考文献4

二级参考文献46

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:239
  • 2<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)ⅩⅦ——骨和关节感染[J].中华外科杂志,2005,43(4):270-272. 被引量:42
  • 3张圣道,雷若庆.重症急性胰腺炎诊治指南[J].中华外科杂志,2007,45(11):727-729. 被引量:1145
  • 4Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012 [ J ]. JAMA, 2014,311 (13) :1308-1316. 被引量:1
  • 5Taccone FS, Laterre PF, Dugernier T, et al. Insufficient 13- laetam concentrations in the early phase of severe sepsis and septic shock[J]. Crit Care,2010,14(4) :R126. 被引量:1
  • 6Roberts JA, Paul SK, Akova M, et, al. DALI : defining antibiotic levels in intensive care unit patients: are current 13-1actam antibiotic doses sufficient for critically ill patients? [ J ]. Clin Infect Dis, 2014, 58(8):1072-1083. 被引量:1
  • 7Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill:challenges and potential solutions[J]. Lancet Infect Dis, 2014,14(6) :498-509. 被引量:1
  • 8Ulldemnlins M, Roberts JA, Lipman J, et al. Antibiotic dosing in muhiple organ dysfunction syndrome [ J ]. Chest, 2011,139 ( 5 ) : 1210-1220. 被引量:1
  • 9Ulldemolins M, Rello J. The relevance of drug volume of distribution in antibiotic dosing [ J ]. CmT Pharm Biotechnol, 2011,12(12) :1996-2001. 被引量:1
  • 10SAFE Study Investigatorsl, Finfer S, Bellomo R, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units:analysis of data from the saline versus albumin fluid evaluation ( SAFE ) study[J]. BMJ, 2006, 333(7577):1044. 被引量:1

共引文献449

同被引文献38

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部